The aim of our study was to investigate the contribution of the
adrenocorticotropic hormone fragment,
ACTH (4-10), on the recovery of postischemic cardiac function. Effects of
ACTH (4-10) on
caspase-3 activity, cardiomyocyte and endothelial apoptosis, and HO-1
protein expression were studied. Rats were treated with various doses of
ACTH (4-10), and then 12 h later, anesthetized, hearts were isolated, perfused, and subjected to 30-min
ischemia followed by 120-min reperfusion. Cardiac function including heart rate, coronary flow, aortic flow, and left ventricular developed pressure were recorded. After 120-min reperfusion, 200 mug/kg of
ACTH (4-10) significantly improved the recovery of aortic flow, coronary flow, and left ventricular developed pressure from their untreated control values of 15.3 +/- 0.9 ml/min, 6.5 +/- 0.9 ml/min, and 10 +/- 0.6 kPa to 20.7 +/- 1.3 ml/min, 24.8 +/- 1.8 ml/min and 13.7 +/- 0.7 kPa, respectively. Heart rate did not show significant changes during reperfusion.
ACTH (4-10) treatment resulted in a reduction in
infarct size,
caspase 3 activity, apoptosis, and an increase in HO-1 expression. When
ACTH (4-10) was given at the moment of reperfusion, the
drug failed to improve the postischemic recovery of the myocardium. Thus,
ACTH (4-10) can be a useful tool for the prevention of the development of
ischemia/reperfusion-induced injury.